Results 281 to 290 of about 8,994,995 (387)

Human Factors: Affect Everyone, Involve Everyone. [PDF]

open access: yesClin Teach
Alcock A   +5 more
europepmc   +1 more source

ENDOTOXIN (LPS) FOLLOWING INTESTINAL ISCHEMIA/REPERFUSION DECREASES SUPERIOR MESENTERY ARTERY (SMA) BLOOD FLOW (BF)

open access: bronze, 1998
Lajos Bogár   +7 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

open access: yesMolecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef   +10 more
wiley   +1 more source

The effects of pregnancy on the progression of maternal glomerular disease. [PDF]

open access: yesJ Bras Nefrol
Marques LPJ   +5 more
europepmc   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

open access: yesMolecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo   +11 more
wiley   +1 more source

ChatGPT performance in answering medical residency questions in nephrology: a pilot study in Brazil. [PDF]

open access: yesJ Bras Nefrol
Feitosa Filho HN   +6 more
europepmc   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy